Introduction: Deregulation of the protein kinase C (PKC) signaling pathway has been implicated in tumor progression.
Aim(s): To investigate the antiproliferative and antisecretory effects of a novel PKC inhibitor (PI) in the human pancreatic endocrine cancer cell line, BON1.
Materials and methods: Cell viability was investigated by ATPlite kit, apoptosis by caspase 3/7 assay, GSK3-ß phosphorylation and Chromogranin A (CgA) secretion by ELISA, PKCßII localization by immunofluorescence, CgA expression by Western blot.
Conference: 8th Annual ENETS Conference (2011)
Presenting Author: MD Maria Chiara Zatelli
To read results and conclusion, please login ...
Further abstracts you may be interested in